In a study published in December 2019, Cattaneo et al. [36] described a method of co-culturing tumor organoids with autologous peripheral blood lymphocytes to generate CD8+ T cells that recognize and kill autologous tumor organoids. This evidence concerns the gene CD8A and neoplasm.